NorthWest Biotherapeutics Inc (NWBO)

[FatCat_Banker]

Seems to me that there's a lot of uncertainty in terms of general sentiments as far as the structuring of the trial.

My question is simple, if NW organized, let's say, the trial favorably to themselves, is this abnormal and a liability in the DMC's eyes?

It seems as most clinical trials would want to test for maximum responsiveness in the healthiest of patients and that this would not be abnormal. Shorts and AF alike like to tote this as a FACT that NW will fail. But it seems ... non-sequitor to me. I mean, here he is debating, and we have to qualify, GBM patients. It doesn't get much worse than GBM, period. It also seems to me that any sort of progress, in any capacity should be availale to the public.

I digress and restate my question: If NW
organized the trial favorably to themselves, is this abnormal in the industry to do so and therefore a liability in the DMC's eyes?





Thanks, guys. You're all awesome! Just as awesome as the charts look!